Physician profile
Dhaval Patel
NPI 1629620471
$9,204.07
in general payments reported to CMS, 2019-2025
16 companies · $995 in 2025
The $995 reported for 2025 was more than what 80% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.56 · 2022: $7,589 · 2023: $450 · 2024: $149 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $833 · Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $833.42 |
| Food and Beverage | $760.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,081.35 | 2022 | |
| Supreme Orthopedic Systems, LLC | $1,293.10 | 2022 | |
| Seapearl East, INC | $1,238.77 | 2022 | |
| Paragon 28, INC. | $1,096.57 | 2022 | |
| Orthofix Medical, INC. | $995.31 | 2025 | Truelok |
| Stryker Corporation | $653.97 | 2022-2024 | N/A, Hoffmann, Dart-Fire |
| Kerecis Limited | $256.42 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Davol INC. | $255.67 | 2022 | |
| Treace Medical Concepts, INC. | $106.32 | 2022 | |
| Smith+Nephew, INC. | $67.41 | 2022-2023 | Collagenase Santyl, Regranex |
| Baxter Healthcare | $57.50 | 2023 | |
| Acera Surgical, INC. | $32.91 | 2022 | |
| Convatec INC. | $20.56 | 2021 | |
| Trice Medical, INC. | $19.66 | 2022 | |
| Cashflow Solutions, LLC | $14.95 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dhaval Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.